Abstract
The etiology and pathology of autism spectrum disorders (ASDs) are still poorly understood, which largely limit the treatment and diagnosis of ASDs. Emerging evidence supports that abnormal metabolites in the cerebral cortex of a BTBR mouse model of autism are involved in the pathogenesis of autism. However, systematic study on global metabolites in the cerebral cortex of BTBR mice has not been conducted. The current study aims to characterize metabolic changes in the cerebral cortex of BTBR mice by using an untargeted metabolomic approach based on UPLC-Q-TOF/MS. C57BL/6 J mice were used as a control group. A total of 14 differential metabolites were identified. Compared with the control group, the intensities of PI(16:0/22:5(4Z,7Z,10Z,13Z,16Z)), PC(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)), PA(16:0/18:1(11Z)), 17-beta-estradiol-3-glucuronide, and N6,N6,N6-trimethyl-L-lysine decreased significantly (p < 0.01) and the intensities of 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline, LysoPC(20:4(5Z,8Z,11Z,14Z)/0:0), adenosine monophosphate, adenosine-5′-phosphosulfate, LacCer(d18:1/12:0),3-dehydro-L-gulonate, N-(1-deoxy-1-fructosyl)tryptophan, homovanillic acid, and LPA(0:0/18:1(9Z)) increased significantly (p < 0.01) in the BTBR group. These changes in metabolites were closely related to perturbations in lipid metabolism, energy metabolism, purine metabolism, sulfur metabolism, amino acid metabolism, and carnitine biosynthesis. Notably, exacerbation of the oxidative stress response caused by differential prooxidant metabolites led to alteration of antioxidative systems in the cerebral cortex and resulted in mitochondrial dysfunction, further leading to abnormal energy metabolism as an etiological mechanism of autism. A central role of abnormal metabolites in neurological functions associated with behavioral outcomes and disturbance of sulfur metabolism and carnitine biosynthesis were found in the cerebral cortex of BTBR mice, which helped increase our understanding for exploring the pathological mechanism of autism.
Similar content being viewed by others
Data Availability
The data that supports the findings of this study are available in supplementary materials.
References
Bavaresco CS, Chiarani F, Kolling J, Netto CA, De Souza Wyse AT (2008) Biochemical effects of pretreatment with vitamins E and C in rats submitted to intrastriatal hypoxanthine administration. Neurochemi Int 52:1276–1283. https://doi.org/10.1016/j.neuint.2008.01.008
Beaudet AL (2017) Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: a hypothesis. BioEssays News Rev Mol Cell Dev Biol 39. https://doi.org/10.1002/bies.201700012
Chatterjee S, Balram A, Li W (2021) Convergence: lactosylceramide-centric signaling pathways induce inflammation, oxidative stress, and other phenotypic outcomes. Int J Mol Sci 22. https://doi.org/10.3390/ijms22041816
Chauhan A, Audhya T, Chauhan V (2012) Brain region-specific glutathione redox imbalance in autism. Neurochem Res 37:1681–1689. https://doi.org/10.1007/s11064-012-0775-4
Chiasson K, Lahaie-Collins V, Bournival J, Delapierre B, Gélinas S, Martinoli MG (2006) Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently. J Mol Neurosci : MN 30:297–310. https://doi.org/10.1385/jmn:30:3:297
Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, Chun J (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50:157–186. https://doi.org/10.1146/annurev.pharmtox.010909.105753
Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF (1997) Special report: The 1996 guide for the care and use of laboratory animals. ILAR J 38:41–48. https://doi.org/10.1093/ilar.38.1.41
Cole DE, Evrovski J (2000) The clinical chemistry of inorganic sulfate. Crit Rev Clin Lab Sci 37:299–344. https://doi.org/10.1080/10408360091174231
De Marchi U, Galindo AN, Thevenet J, Hermant A, Bermont F, Lassueur S, Domingo JS, Kussmann M, Dayon L, Wiederkehr A (2019) Mitochondrial lysine deacetylation promotes energy metabolism and calcium signaling in insulin-secreting cells. FASEB J Official Publ Fed Am Soc Exp Biol 33:4660–4674. https://doi.org/10.1096/fj.201801424R
El-Ansary AK, Bacha AG, Al-Ayahdi LY (2011) Impaired plasma phospholipids and relative amounts of essential polyunsaturated fatty acids in autistic patients from Saudi Arabia. Lipids Health Dis 10:63. https://doi.org/10.1186/1476-511x-10-63
El-Ansary A, Bjørklund G, Chirumbolo S, Alnakhli OM (2017) Predictive value of selected biomarkers related to metabolism and oxidative stress in children with autism spectrum disorder. Metab brain Dis 32:1209–1221. https://doi.org/10.1007/s11011-017-0029-x
Fenlon LR, Liu S, Gobius I, Kurniawan ND, Murphy S, Moldrich RX, Richards LJ (2015) Formation of functional areas in the cerebral cortex is disrupted in a mouse model of autism spectrum disorder. Neural Dev 10:10. https://doi.org/10.1186/s13064-015-0033-y
Filice F, Lauber E, Vörckel KJ, Wöhr M, Schwaller B (2018) 17-β estradiol increases parvalbumin levels in Pvalb heterozygous mice and attenuates behavioral phenotypes with relevance to autism core symptoms. Mol Autism 9:15.https://doi.org/10.1186/s13229-018-0199-3
Flannery BM, Silverman JL, Bruun DA, Puhger KR, McCoy MR, Hammock BD, Crawley JN, Lein PJ (2015) Behavioral assessment of NIH Swiss mice acutely intoxicated with tetramethylenedisulfotetramine. Neurotoxicol Teratol 47:36–45. https://doi.org/10.1016/j.ntt.2014.10.008
Geier DA, Kern JK, Geier MR (2019) Down syndrome as a genetic model to evaluate the role of oxidative stress and transsulfuration abnormalities in autism spectrum disorder: a 10-year longitudinal cohort study. Dev Neurobiol 79:857–867. https://doi.org/10.1002/dneu.22726
Gevi F, Zolla L, Gabriele S, Persico AM (2016) Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol Autism 7:47. https://doi.org/10.1186/s13229-016-0109-5
Gu F, Chauhan V, Chauhan A (2015) Glutathione redox imbalance in brain disorders. Curr Opin Clin Nutr Metab Care 18:89–95. https://doi.org/10.1097/mco.0000000000000134
Guo YP, Commons KG (2017) Serotonin neuron abnormalities in the BTBR mouse model of autism. Autism Res Official J Int Soc Autism Res 10:66–77. https://doi.org/10.1002/aur.1665
Gross C (2017) Defective phosphoinositide metabolism in autism. J Neurosci Res 95:1161–1173. https://doi.org/10.1002/jnr.23797
Harkness RA (1988) Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP depletion. J Chromatogr 429:255–278. https://doi.org/10.1016/s0378-4347(00)83873-6
Hojo Y, Hattori TA, Enami T, Furukawa A, Suzuki K, Ishii HT, Mukai H, Morrison JH, Janssen WG, Kominami S, Harada N, Kimoto T, Kawato S (2004) Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons. Proc Natl Acad Sci USA 101:865–870. https://doi.org/10.1073/pnas.2630225100
James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutri 80:1611–1617. https://doi.org/10.1093/ajcn/80.6.1611
Jiang M, Ni J, Cao Y, Xing X, Wu Q, Fan G (2019) Astragaloside IV attenuates myocardial ischemia-reperfusion injury from oxidative stress by regulating succinate, lysophospholipid metabolism, and ROS scavenging system. Oxid Med Cell Longev 2019:9137654. https://doi.org/10.1155/2019/9137654
Joshi L, Plastira I, Bernhart E, Reicher H, Koyani CN, Madl T, Madreiter-Sokolowski C, Koshenov Z, Graier WF, Hallström S, Sattler W (2021) Lysophosphatidic acid induces aerobic glycolysis, lipogenesis, and increased amino acid uptake in BV-2 microglia. Int J Mol Sci 22. https://doi.org/10.3390/ijms22041968
Khan ZUN, Chand P, Majid H, Ahmed S, Khan AH, Jamil A, Ejaz S, Wasim A, Khan KA, Jafri L (2022) Urinary metabolomics using gas chromatography-mass spectrometry: potential biomarkers for autism spectrum disorder. BMC Neurol 22:101. https://doi.org/10.1186/s12883-022-02630-4
Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther GB, Dittrich C, Visser A, Wang W, Hsu FF, Wiehart U, Tsenova L, Kaplan G, Russell DG (2010) Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol Med 2:258–274. https://doi.org/10.1002/emmm.201000079
Lavelle TA, Weinstein MC, Newhouse JP, Munir K, Kuhlthau KA, Prosser LA (2014) Economic burden of childhood autism spectrum disorders. Pediatrics 133:e520-529. https://doi.org/10.1542/peds.2013-0763
Li XS, Wang Z, Cajka T, Buffa JA, Nemet I, Hurd AG, Gu X, Skye SM, Roberts AB, Wu Y, Li L, Shahen CJ, Wagner MA, Hartiala JA, Kerby RL, Romano KA, Han Y, Obeid S, Lüscher TF, Allayee H, Rey FE, DiDonato JA, Fiehn O, Tang WHW, Hazen SL (2018) Untargeted metabolomics identifies trimethyllysine, a TMAO-producing nutrient precursor, as a predictor of incident cardiovascular disease risk. JCI Insight 3. https://doi.org/10.1172/jci.insight.99096
Lu Q, Murakami C, Murakami Y, Hoshino F, Asami M, Usuki T, Sakai H, Sakane F (2020) 1-Stearoyl-2-docosahexaenoyl-phosphatidic acid interacts with and activates Praja-1, the E3 ubiquitin ligase acting on the serotonin transporter in the brain. FEBS Lett 594:1787–1796. https://doi.org/10.1002/1873-3468.13765
Luine VN (2014) Estradiol and cognitive function: past, present and future. Horm Behav 66:602–618. https://doi.org/10.1016/j.yhbeh.2014.08.011
Lv QQ, You C, Zou XB, Deng HZ (2018) Acyl-carnitine, C5DC, and C26 as potential biomarkers for diagnosis of autism spectrum disorder in children. Psychiatry Res 267:277–280. https://doi.org/10.1016/j.psychres.2018.06.027
McFarlane HG, Kusek GK, Yang M, Phoenix JL, Bolivar VJ, Crawley JN (2008) Autism-like behavioral phenotypes in BTBR T+tf/J mice. Genes Brain Behav 7:152–163. https://doi.org/10.1111/j.1601-183X.2007.00330.x
McTighe SM, Neal SJ, Lin Q, Hughes ZA, Smith DG (2013) The BTBR mouse model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex. PloS One 8:e62189. https://doi.org/10.1371/journal.pone.0062189
Mercier F, Kwon YC, Douet V (2012) Hippocampus/amygdala alterations, loss of heparan sulfates, fractones and ventricle wall reduction in adult BTBR T+ tf/J mice, animal model for autism. Neurosci Lett 506:208–213. https://doi.org/10.1016/j.neulet.2011.11.007
Moghaddam B, Javitt D (2012) From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacol Official Publ Am College Neuropsychopharmacol 37:4–15. https://doi.org/10.1038/npp.2011.181
Murray EA, Wise SP (2010) Interactions between orbital prefrontal cortex and amygdala: advanced cognition, learned responses and instinctive behaviors. Curr Opin Neurobiol 20:212–220. https://doi.org/10.1016/j.conb.2010.02.001
Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Alshammari MA, Alzahrani KS, Bakheet SA (2019) Increased oxidative stress in the cerebellum and peripheral immune cells leads to exaggerated autism-like repetitive behavior due to deficiency of antioxidant response in BTBR T + tf/J mice. Prog Neuro-Psychopharmacol Biol Psychiatry 89:245–253. https://doi.org/10.1016/j.pnpbp.2018.09.012
Nakamura H, Moriyama Y, Makiyama T, Emori S, Yamashita H, Yamazaki R, Murayama T (2013) Lactosylceramide interacts with and activates cytosolic phospholipase A2α. J Biol Chem 288:23264–23272. https://doi.org/10.1074/jbc.M113.491431
Needham BD, Adame MD, Serena G, Rose DR, Preston GM, Conrad MC, Campbell AS, Donabedian DH, Fasano A, Ashwood P, Mazmanian SK (2021) Plasma and fecal metabolite profiles in autism spectrum disorder. Biol Psychiatry 89:451–462. https://doi.org/10.1016/j.biopsych.2020.09.025
Newell C, Shutt TE, Ahn Y, Hittel DS, Khan A, Rho JM, Shearer J (2016) Tissue specific impacts of a ketogenic diet on mitochondrial dynamics in the BTBR(T+tf/j) mouse. Front Physiol 7:654. https://doi.org/10.3389/fphys.2016.00654
Nicholson JK, Wilson ID (2003) Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2:668–676. https://doi.org/10.1038/nrd1157
Nilsen J (2008) Estradiol and neurodegenerative oxidative stress. Front Neuroendocrinol 29:463–475. https://doi.org/10.1016/j.yfrne.2007.12.005
Nuzzo T, Sekine M, Punzo D, Miroballo M, Katane M, Saitoh Y, Galbusera A, Pasqualetti M, Errico F, Gozzi A, Mothet JP, Homma H, Usiello A (2020) Dysfunctional d-aspartate metabolism in BTBR mouse model of idiopathic autism. Biochim Biophys Acta Proteins Proteom 1868:140531. https://doi.org/10.1016/j.bbapap.2020.140531
Ojo JO, Algamal M, Leary P, Abdullah L, Mouzon B, Evans JE, Mullan M, Crawford F (2018) Disruption in brain phospholipid content in a humanized tau transgenic model following repetitive mild traumatic brain injury. Front Neurosci 12:893. https://doi.org/10.3389/fnins.2018.00893
Ong WY, Farooqui T, Kokotos G, Farooqui AA (2015) Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders. ACS Chem Neurosci 6:814–831. https://doi.org/10.1021/acschemneuro.5b00073
Page T, Coleman M (2000) Purine metabolism abnormalities in a hyperuricosuric subclass of autism. Biochim Biophys Acta 1500:291–296. https://doi.org/10.1016/s0925-4439(99)00113-1
Pavăl D (2017) A dopamine hypothesis of autism spectrum disorder. Dev Neurosci 39:355–360. https://doi.org/10.1159/000478725
Raben DM, Barber CN (2017) Phosphatidic acid and neurotransmission. Adv Biol Regul 63:15–21. https://doi.org/10.1016/j.jbior.2016.09.004
Rossignol DA, Frye RE (2012) A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry 17:389–401. https://doi.org/10.1038/mp.2011.165
Saide A, Lauritano C, Ianora A (2021) A treasure of bioactive compounds from the deep sea. Biomedicines 9. https://doi.org/10.3390/biomedicines9111556
Savio LEB, Leite-Aguiar R, Alves VS, Coutinho-Silva R, Wyse ATS (2021) Purinergic signaling in the modulation of redox biology. Redox Biol 47:102137. https://doi.org/10.1016/j.redox.2021.102137
Sbodio JI, Snyder SH, Paul BD (2019) Regulators of the transsulfuration pathway. Br J Pharmacol 176:583–593. https://doi.org/10.1111/bph.14446
Takenouchi T, Sato M, Kitani H (2007) Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J Neurochem 102:1518–1532. https://doi.org/10.1111/j.1471-4159.2007.04570.x
Thapar A, Rutter M (2021) Genetic advances in autism. J Autism Dev Disord 51:4321–4332. https://doi.org/10.1007/s10803-020-04685-z
Toczylowska B, Zieminska E, Senator P, Lazarewicz JW (2020) Hippocampal metabolite profiles in two rat models of autism: NMR-based metabolomics studies. Mol Neurobiol 57:3089–3105. https://doi.org/10.1007/s12035-020-01935-0
Wang H, Liang S, Wang M, Gao J, Sun C, Wang J, Xia W, Wu S, Sumner SJ, Zhang F, Sun C, Wu L (2016) Potential serum biomarkers from a metabolomics study of autism. J Psychiatry Neurosci : JPN 41:27–37. https://doi.org/10.1503/jpn.140009
Wang L, Peng JL, Qiao FQ, Cheng WM, Lin GW, Zhang Y, Gao TG, Sun YY, Tang WZ, Wang P (2021) Clinical randomized controlled study of acupuncture treatment on children with autism spectrum disorder (ASD): a systematic review and meta-analysis. Evid Based Complement Alternat Med eCAM 2021:5549849. https://doi.org/10.1155/2021/5549849
Wei H, Ma Y, Ding C, Jin G, Liu J, Chang Q, Hu F, Yu L (2016) Reduced glutamate release in adult BTBR mouse model of autism spectrum disorder. Neurochem Res 41:3129–3137. https://doi.org/10.1007/s11064-016-2035-5
Wei H, Ma Y, Liu J, Ding C, Hu F, Yu L (2016) Proteomic analysis of cortical brain tissue from the BTBR mouse model of autism: evidence for changes in STOP and myelin-related proteins. Neuroscience 312:26–34. https://doi.org/10.1016/j.neuroscience.2015.11.003
Weng R, Shen S, Yang L, Li M, Tian Y, Bai Y, Liu H (2015) Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry. Rapid Commun Mass Spectrom : RCM 29:1491–1500. https://doi.org/10.1002/rcm.7241
Yao HY, Xue HW (2018) Phosphatidic acid plays key roles regulating plant development and stress responses. J Integr Plant Biol 60:851–863. https://doi.org/10.1111/jipb.12655
Yu W, Ying J, Wang X, Liu X, Zhao T, Yoon S, Zheng Q, Fang Y, Yang D, Hua F (2021) The involvement of lactosylceramide in central nervous system inflammation related to neurodegenerative disease. Front Aging Neurosci 13:691230. https://doi.org/10.3389/fnagi.2021.691230
Yun DH, Jeon ES, Sung SM, Ryu SH, Kim JH (2006) Lysophosphatidylcholine suppresses apoptosis and induces neurite outgrowth in PC12 cells through activation of phospholipase D2. Exp Mol Med 38:375–384. https://doi.org/10.1038/emm.2006.44
Yung YC, Stoddard NC, Mirendil H, Chun J (2015) Lysophosphatidic acid signaling in the nervous system. Neuron 85:669–682. https://doi.org/10.1016/j.neuron.2015.01.009
Funding
This work was supported by the National Natural Science Foundation of China under grant number [81874269]; The Innovative Science Foundation of Harbin Medical University under grant number [31041210066]; Innovation and entrepreneurship training program for college students of Harbin Medical University under grant number [202210226164].
Author information
Authors and Affiliations
Contributions
Lijie Wu conceived and designed the study. Can Cao performed the assay of experimental detection and analyzed the data. Qi Li, Yanping Chen, and Xiangning Li analyzed the data. Can Cao drafted the manuscript. Mingyang Zou, Caihong Sun, and Lijie Wu provided constructive opinions and suggestions. Can Cao and Lijie Wu reviewed and made improvements in the manuscript. All authors read and approved the final version of the paper.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Cao, C., Li, Q., Chen, Y. et al. Untargeted Metabolomic Analysis Reveals the Metabolic Disturbances and Exacerbation of Oxidative Stress in the Cerebral Cortex of a BTBR Mouse Model of Autism. J Mol Neurosci 73, 15–27 (2023). https://doi.org/10.1007/s12031-022-02096-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-022-02096-6